Targeted Radiation Therapy for Ovarian Cancer: Intraperitoneal Treatment With 211-astatine-MX35 F(ab')2
Condition: Ovarian Cancer Intervention: Combination Product: 211-astatine MX35 F(ab')2 Sponsors: Vastra Gotaland Region; Swedish Cancer Society; The Swedish Research Council; Sahlgrenska University Hospital, Sweden Completed
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Hospitals | Ovarian Cancer | Ovaries | Radiation Therapy | Research | Sweden Health